• Home
  • Search Results
  • Comparative toxicity of nanoparticulate/bulk Yb₂O₃ and YbCl₃ to cucumber (Cucumis sativus).

Comparative toxicity of nanoparticulate/bulk Yb₂O₃ and YbCl₃ to cucumber (Cucumis sativus).

Environmental science & technology (2011-12-24)
Peng Zhang, Yuhui Ma, Zhiyong Zhang, Xiao He, Zhi Guo, Renzhong Tai, Yayun Ding, Yuliang Zhao, Zhifang Chai

With the increasing utilization of nanomaterials, there is a growing concern for the potential environmental and health effects of them. To assess the environmental risks of nanomaterials, better knowledge about their fate and toxicity in plants are required. In this work, we compared the phytotoxicity of nanoparticulate Yb(2)O(3), bulk Yb(2)O(3), and YbCl(3)·6H(2)O to cucumber plants. The distribution and biotransformation of the three materials in plant roots were investigated in situ by TEM, EDS, as well as synchrotron radiation based methods: STXM and NEXAFS. The decrease of biomass was evident at the lowest concentration (0.32 mg/L) when exposed to nano-Yb(2)O(3), while at the highest concentration, the most severe inhibition was from YbCl(3). The inhibition was dependent on the actual amount of toxic Yb uptake by the cucumber plants. In the intercellular regions of the roots, Yb(2)O(3) particles and YbCl(3) were all transformed to YbPO(4). We speculate that the dissolution of Yb(2)O(3) particles induced by the organic acids exuded from roots played an important role in the phytotoxicity. Only under the nano-Yb(2)O(3) treatment, YbPO(4) deposits were found in the cytoplasm of root cells, so the phytotoxicity might also be attributed to the Yb internalized into the cells.

Product Number
Product Description

Ytterbium(III) chloride, AnhydroBeads, −10 mesh, 99.99% trace metals basis
Ytterbium(III) chloride, anhydrous, powder, 99.9%

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.